Boosted leave-many-out cross-validation: the effect of training and test set diversity on PLS statistics.
It is becoming increasingly common in quantitative structure/activity relationship (QSAR) analyses to use external test sets to evaluate the likely stability and predictivity of the models obtained. In some cases, such as those involving variable selection, an internal test set--i.e., a cross-validation set--is also used. Care is sometimes taken to ensure that the subsets used exhibit response and/or property distributions similar to those of the data set as a whole, but more often the individual observations are simply assigned 'at random.' In the special case of MLR without variable selection, it can be analytically demonstrated that this strategy is inferior to others. Most particularly, D-optimal design performs better if the form of the regression equation is known and the variables involved are well behaved. This report introduces an alternative, non-parametric approach termed 'boosted leave-many-out' (boosted LMO) cross-validation. In this method, relatively small training sets are chosen by applying optimizable k-dissimilarity selection (OptiSim) using a small subsample size (k = 4, in this case), with the unselected observations being reserved as a test set for the corresponding reduced model. Predictive errors for the full model are then estimated by aggregating results over several such analyses. The countervailing effects of training and test set size, diversity, and representativeness on PLS model statistics are described for CoMFA analysis of a large data set of COX2 inhibitors.
D000465:Algorithms; D003198:Computer Simulation; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000737:chemistry / Q000494:pharmacology; D015195:Drug Design; D007527:Isoenzymes / Q000037:antagonists & inhibitors; D016018:Least-Squares Analysis; D008956:Models, Chemical; D008958:Models, Molecular; D015394:Molecular Structure; D011451:Prostaglandin-Endoperoxide Synthases; D021281:Quantitative Structure-Activity Relationship; D012044:Regression Analysis; D012986:Software Validation; D018709:Statistics, Nonparametric
D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D051546:Cyclooxygenase 2; D011451:Prostaglandin-Endoperoxide Synthases